Global Markets

Additional European Equity News - 27th August 2026

StockNow breaking-news AI analysis

AstraZeneca and Amgen reported positive Phase 3 trial results for Tezspire in treating eosinophilic esophagitis, demonstrating sustained improvements across co-primary and key secondary endpoints through week 52.

News detail

AstraZeneca (AZN LN), Amgen (AMGN) - Cos announce that its Tezspire demonstrated statistically significant and clinically meaningful improvements across co-primary and key secondary endpoints at week 24 from the Phase 3 CROSSING trial in patients living with eosinophilic esophagitis. (PR Newswire) Kuehne+Nagel (KNIN SW), Super Micro (SMCI), Nvidia (NVDA) - US authorities are investigating Singapore-based Apex Logistics over suspected shipments of Nvidia-powered Super Micro systems to China in breach of export controls, Bloomberg reports. It is examining 47 shipments from 2024. Apex and parent Kuehne+Nagel said the company is cooperating, while Nvidia and Super Micro have not been accused of any wrongdoing. (Bloomberg) TotalEnergies (TTE FP) - Completes the transfer of its 10% interest in Arctic LNG 2. (TotalEnergies) Amundi (AMUN FP) downgraded to Neutral from Buy at ESN Bilfinger (GBF GY) upgraded to Buy from Neutral at UBS Novo Nordisk (NOVOB DC) downgraded to Sell from Hold at Deutsche Bank

5 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more